Change Language

Select Language

Global Kidney/Renal Function Test Market to Grow at 6% During 2021-2026, Augmented by Rising Incidences of Chronic Kidney Diseases (CRDs)

Published on Sep 03, 2021

According to the latest report by IMARC Group, titled “Kidney/Renal Function Teste Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global kidney/renal function test market exhibited moderate growth during 2015-2020. A kidney/renal function test is conducted to investigate and evaluate kidney functions when a patient experiences discomfort during urination, blood in urine, muscle cramping, and poor appetite. It includes several blood and urine tests to identify the presence of various substances, including minerals, electrolytes, proteins, and glucose, in the blood. It helps in monitoring the response of kidneys to treatment and determining the progression of the disease.  

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Kidney/Renal Function Test Market Trends:

Due to the rising number of individuals who consume alcohol and smoke excessively, there is an increase in the occurrences of chronic kidney diseases (CKD) worldwide. This represents one of the key factors positively influencing the demand for effective diagnosis of kidney disorders. Additionally, there is a considerable rise in the COVID-19 patients who are developing acute kidney injuries (AKIs). This, along with the growing geriatric population, is also creating a positive market outlook. Furthermore, there is a rapid increase in research and development (R&D) activities across the globe. This, in confluence with the rising healthcare expenditure and easy availability of technologically advanced products, is propelling the growth of the market. Looking forward, IMARC Group expects the market to expand at a CAGR of around 6% during the forecast period (2021-2026).

Market Summary:

  • Based on the test type, urine tests hold the largest market share, followed by blood tests.
  • On the basis of the product, the market has been divided into dipsticks, reagents, and disposables. At present, dipsticks account for the majority of the total market share.
  • Based on the end use, the market has been classified into hospitals, diagnostic laboratories, research laboratories and institutes, and others. Presently, hospitals dominate the global market.
  • Region-wise, the market has been categorized into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. Amongst these, North America enjoys the leading position in the market.
  • The competitive landscape of the market has been examined, with some of the key players being 77 Elektronika Kft., Abbott Laboratories, Acon Laboratories, Inc., Arkray, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Nova Biomedical, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Siemens Healthcare GmbH, and Sysmex Corporation.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

USA: +1-631-791-1145
Follow us on twitter: @imarcglobal


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at